Hims & Hers Health, Inc. logo

Hims & Hers Health, Inc. (82W)

Market Open
11 Jul, 20:00
XBER XBER
40. 95
-2.34
-5.41%
6.66B Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-0.14 Eps
43.29
Previous Close
Day Range
40.95 43.03
Year Range
12.18 68.66
Want to track 82W and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 24 days

Summary

82W trading today lower at €40.95, a decrease of 5.41% from yesterday's close, completing a monthly decrease of -2.73% or €1.15. Over the past 12 months, 82W stock gained 71.05%.
82W is not paying dividends to its shareholders.
The last earnings report, released on Jun 06, 2025, missed the consensus estimates by -0.01%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports. The next scheduled earnings report is due on Aug 11, 2025.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

82W Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?

Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?

HIMS benefits from strong online revenue, subscriber growth, and global expansion moves to fuel its health platform momentum. However, challenges may hurt performance.

Zacks | 14 hours ago
Why Hims & Hers Management Might Be Its Most Valuable Asset

Why Hims & Hers Management Might Be Its Most Valuable Asset

Hims & Hers Health is a telehealth leader with strong revenue growth, innovative personalized solutions, and ambitious global expansion plans. Despite traditional valuation metrics suggesting overvaluation, I see long-term growth potential driven by top management strategic decisions, AI, new products, and international markets. Key risks include high stock-based compensation, regulatory scrutiny around compounded drugs, and intensifying competition from major healthcare players.

Seekingalpha | 2 days ago
Hims & Hers to offer generic semaglutide in Canada starting in 2026

Hims & Hers to offer generic semaglutide in Canada starting in 2026

Hims & Hers (NYSE:HIMS) announced plans to expand its digital health and weight loss services to Canada in 2026, coinciding with the first global availability of generic semaglutide. Beginning in January 2026, Canada will become the first country to offer generic versions of semaglutide, a GLP-1 receptor agonist widely used for weight management under brand names such as Wegovy and Ozempic.

Proactiveinvestors | 1 week ago

Hims & Hers Health, Inc. Dividends

82W is not paying dividends to its shareholders.

Hims & Hers Health, Inc. Earnings

11 Aug 2025 (In 3 weeks) Date
0.15
Cons. EPS
-
EPS
6 Jun 2025 Date
0.01
Cons. EPS
-
EPS
5 May 2025 Date
0.12
Cons. EPS
0.2
EPS
24 Feb 2025 Date
0.22
Cons. EPS
0.23
EPS
4 Nov 2024 Date
0.04
Cons. EPS
0.32
EPS
82W is not paying dividends to its shareholders.
11 Aug 2025 (In 3 weeks) Date
0.15
Cons. EPS
-
EPS
6 Jun 2025 Date
0.01
Cons. EPS
-
EPS
5 May 2025 Date
0.12
Cons. EPS
0.2
EPS
24 Feb 2025 Date
0.22
Cons. EPS
0.23
EPS
4 Nov 2024 Date
0.04
Cons. EPS
0.32
EPS

Hims & Hers Health, Inc. (82W) FAQ

What is the stock price today?

The current price is €40.95.

On which exchange is it traded?

Hims & Hers Health, Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is 82W.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 6.66B.

What is the earnings per share?

The EPS is 0.15.

When is the next earnings date?

The next earnings report will release on Aug 11, 2025.

Has Hims & Hers Health, Inc. ever had a stock split?

No, there has never been a stock split.

Hims & Hers Health, Inc. Profile

Household & Personal Products Industry
Consumer Defensive Sector
Andrew Dudum CEO
XBER Exchange
US4330001060 ISIN
US Country
1,637 Employees
- Last Dividend
- Last Split
13 Sep 2019 IPO Date

Overview

Hims & Hers Health, Inc., based in San Francisco, California, operates as a telehealth platform connecting consumers with licensed healthcare professionals across the United States, the United Kingdom, and other international locations. The company leverages its websites and mobile application to offer a variety of carefully selected health and wellness products and services, both on prescription and over-the-counter basis. Its business model focuses on providing convenient access to ongoing healthcare services, including prescription medication refills and consultations with healthcare providers, as well as a wide range of wellness products through direct sales and wholesale partnerships.

Products and Services

  • Prescription Medication: Customers can receive prescription medication on a recurring basis, ensuring continuous care and support from healthcare providers.
  • Over-The-Counter Drug and Device Products: Offers a selection of non-prescription products, including cosmetics and supplements, focused on general wellness, sexual health, skincare, and hair care.
  • Curated Non-Prescription Products: This includes:
    • Wellness Specialty: Products like melatonin for sleep and biotin for wellness.
    • Skincare Specialty: A range of skincare products including moisturizers, creams, sunscreen, serum, face oil, and face wash.
    • Sexual Health and Wellness Specialty: Items such as condoms, climax delay spray and wipes, vibrators, and lubricants.
    • Hair Care Specialty: Products like shampoos, conditioners, scalp scrubs, and topical treatments, including minoxidil.
  • Medical Consultation and Post-Consultation Support Services: Offers comprehensive consultation services and follow-up support to ensure effective healthcare management.
  • Health and Wellness Products through Wholesale Partners: Besides direct sales, the company expands its reach by distributing health and wellness products through trusted wholesale partners.

Contact Information

Address: 2269 Chestnut Street
Phone: 415 851 0195